Pictet & Cie (Europe) Sa Natera, Inc. Transaction History
Pictet & Cie (Europe) Sa
- $4.53 Billion
- Q4 2024
A detailed history of Pictet & Cie (Europe) Sa transactions in Natera, Inc. stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 1,754 shares of NTRA stock, worth $302,021. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,754
Previous 1,979
11.37%
Holding current value
$302,021
Previous $251,000
10.36%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding NTRA
# of Institutions
571Shares Held
121MCall Options Held
308KPut Options Held
177K-
Vanguard Group Inc Valley Forge, PA12.3MShares$2.12 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.17 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$798 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$785 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$691 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...